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Human cytomegalovirus (HCMV) open reading frames (ORFs) UL93 through UL99 are contained within a
region of viral genome that is well conserved in all herpesviruses. Previous reports detailing the expression of
ORF UL99 (also referred to as the 28-kDa virion phosphoprotein or pp28) indicated that the pattern of
transcription proximal to pp28 is extremely complex and involves a number of large overlapping transcripts,
none of which have been characterized. We have used an RNA-mapping approach consisting of Northern
(RNA) hybridization, RNase protection, and primer extensions to determine the coding capacity of several
large-molecular-weight transcripts which overlap the 1.3- and 1.6-kb UL99-specific transcripts. Our results
suggest that six differentially regulated transcripts with sizes of 2.6, 4.7, 5.6, 7.3, 9.1, and 10.5 kb, and derived
from the same strand of the viral genome overlap, are 3*-coterminal with the smaller UL99-specific transcripts.
On the basis of 5*-end mapping via primer extension and RNase protection, we have determined that the 2.6-
to 10.5-kb messages initiate upstream of each of the potential ORFs in this region, UL98, UL97, UL96, UL95,
UL94, and UL93. By using cycloheximide and ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)guanine] to block
de novo viral protein synthesis and viral DNA replication, respectively, we have determined that the 2.6-, 4.7-,
5.6-, and 7.3-kb messages have characteristics of early or early-late transcripts, whereas the 9.1- and 10.5-kb
messages appear to be true late transcripts. The evolutionary conservation of ORFs UL93 through UL99 and
their transcriptional regulation in other herpesviruses are discussed.
Human cytomegalovirus (HCMV) is a large, double-
stranded DNA virus with the largest genome (240 kb) of the
known human herpesviruses (14). It is widely disseminated
throughout the population and is associated with a variety of
clinical manifestations, including encephalitis, retinitis, enter-
itis, hepatitis, pneumonitis, and immune system dysregulation,
which result from both primary and persistent viral infection
(reviewed in references 2 and 83). Additionally, HCMV is
thought to play a major role in the acquisition of symptomatic
disease by immunocompromised hosts, including neonates, pa-
tients with AIDS, and organ transplant recipients (reviewed in
reference 2). The wide range of disease syndromes associated
with HCMV infection is thought to be due at least in part to
the complex interactions between virus and the host cell which
are consequential to the establishment and maintenance of
persistent viral infection. As an example, HCMV has been
shown to encode proteins homologous to several regulators of
cellular cytokine function, including the T-cell receptor g sub-
unit (14) and the major histocompatibility class I antigen
(HLA) (8), which are thought to play a direct role in the
activation of an abnormal and protracted immune response
seen in some HCMV patients.
Infection of permissive cells in culture by HCMV leads to a
productive viral infection resulting from a coordinated cascade
of viral gene expression that is similar, albeit protracted, to that
exhibited by herpes simplex virus, the archetypal human her-
pesvirus (reviewed in reference 59). Three broad classes of
gene expression, referred to as immediate-early, early, and
late, can be observed. Immediate-early genes are functionally
defined as genes which are transcriptionally activated in the
absence of de novo protein synthesis. The protein products of
immediate-early genes are often regulators of subsequent viral
gene expression; examples include the IE72 and IE86 proteins
(35, 67–70, 77, 78), as well as TRS1 (66), US3 (16, 80), and
UL36-38 (17, 73, 81). Early genes, on the other hand, are
defined as those genes that are transcriptionally activated only
following prior viral gene expression. The protein products of
viral early genes are often directly involved in replication of the
viral genome and as such are expressed prior to or concomitant
with viral DNA replication. The principal example of an
HCMV early gene is the viral DNA polymerase gene, whose
expression is transcriptionally regulated by the viral IE72 and
IE86 proteins (67); other early genes have also been docu-
mented (3, 8, 12, 23, 24, 34, 41, 49, 54, 60, 65, 75, 77, 78, 80–82).
Finally, the late genes are defined as those genes that are
transcriptionally activated only after the onset of viral DNA
replication; the proteins encoded by late genes are generally
structural constituents of mature virus progeny or are enzy-
matically involved in the maturation process itself (19, 20, 23,
33, 40, 45–49, 52, 53, 55, 75, 77). One example of a known
HCMV late gene is pp28 (UL99) (25, 52, 53, 55, 56).
HCMV gene expression also appears to be regulated at the
posttranscriptional level, as demonstrated in studies of the
EcoRI R and d fragments (82) and the ICP36 family of pro-
teins (30, 31). In these studies, two families of proteins en-
coded on overlapping and differentially processed transcripts
appeared with different kinetics during infection, despite being
transcribed with similar kinetics. This has led to the specula-
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tion that posttranscriptional controls are common regulatory
features of HCMV gene expression. The ultimate result of this
complex set of viral gene expression is the production of in-
fectious virus progeny, which are secreted from the cell fully
competent to infect other cells and reiterate the entire process.
As summarized above, the regulation of HCMV gene ex-
pression appears to be controlled through a complex set of
transcriptional and posttranscriptional mechanisms. However,
many of the controls, including both important cis-regulatory
sequences and trans-acting proteins (viral and cellular), as well
as the organization of HCMV transcription units, are at
present poorly defined. In this report, we describe the exis-
tence of a large family of structurally polycistronic transcripts
having the capacity to encode HCMV open reading frames
(ORFs) UL99, UL98, UL97, UL96, UL95, UL94, and UL93.
All of these transcripts appear to utilize a common polyade-
nylation site downstream of ORF UL99, and yet they are not
coordinately expressed during the HCMV replication cycle.
The results of this study demonstrate an extreme example of
the organization of HCMV ORFs into structurally polycis-
tronic, overlapping transcription units and provide evidence
for a family of nested 39-coterminal transcripts that are not
coordinately regulated. The implications of these findings in
terms of the organization of HCMV transcription units, the
potential functions of the UL93 through UL99 gene products,
and the evolutionary conservation of this phenomena in other
human herpesviruses are discussed.
MATERIALS AND METHODS
Cells and virus. Human embryonic lung cells (HELs) were maintained in
Dulbecco modified Eagle medium supplemented with 10% fetal calf serum,
tetracycline, penicillin, and streptomycin. Infection of HELs with HCMV
(Towne strain) was carried out in Dulbecco modified Eagle medium supple-
mented with 6% heat-inactivated fetal calf serum and the antibiotics listed above
as described previously (37). For drug block experiments, the medium described
above was supplemented with either 10 mM [9-(1,3-dihydroxy-2-propoxymethyl)
guanine; ganciclovir] or 50 mg of cycloheximide per ml.
DNA cloning and plasmids. HCMV genomic clones containing sequences for
the UL93 through UL99 region were subcloned from plasmids pHD1 and pHD2
(22). Plasmid p7zXS was generated by digesting pHD2 with XhoI and SalI; the
2.3-kb SalI-XhoI fragment was gel purified, eluted from agarose by using Gene-
clean (Midwest Scientific), and cloned into SalI-cut pGEM-7zf(1) (Promega).
Plasmid p7z97P was generated by cloning a 1.0-kb EcoRI-BamHI fragment from
pHD2 into EcoRI-BamHI-cut pGEM-7zf(1). Plasmid p97Sal-2 was subse-
quently generated from p7z97P by digestion of this plasmid with SalI and sub-
cloning the 324-bp SalI fragment into SalI-digested pBS(1). Plasmid p97ES-1
was also generated from p7z97P by digestion with EcoRI plus SalI and subse-
quent cloning of the 529-bp fragment into EcoRI-SalI-cut pBS(1).
For subcloning of plasmid pBSUL95P, the 4.0-kb EcoRI S fragment was
cloned from HCMV (Towne) genomic DNA by digestion with EcoRI and sub-
sequent ligation into EcoRI-cut pBS(1). White colonies were screened by colony
hybridization with [a-32P]dATP (10 mCi/ml; Amersham)-labeled, nick-trans-
lated UL94-specific probe generated by PCR amplification from HMCV
genomic DNA (81b). The resultant plasmid (pBSES-1) was digested with EcoRI
plus BamHI, and the 1.0-kb fragment was subcloned into BamHI-EcoRI-cut
pBS(1) to generate plasmid pBSUL95P.
Plasmid p93S1-10 was generated by PCR amplification from plasmid pHD1
(22), using the primers 59ACGTACGTGAATTCCCAGAACGCGTTTACCGA
GGAGATCCAG39 and 59ACGTACGTCTGGAGCGCCAGATCCGAATAC
AGGTGCGTTTCC39. The amplified product was digested with EcoRI and PstI
and cloned into pBS(1) cut with EcoRI and PstI.
Oligonucleotide probes. Single-stranded oligonucleotides were synthesized at
the Lineberger Comprehensive Cancer Center Oligonucleotide Facility. Partially
purified oligonucleotides were purified on polyacrylamide-urea gels as described
previously (5) and visualized by UV shadowing. Bands were excised from the gel,
crushed with a spatula, and eluted overnight at 378C in elution buffer (0.5 M
ammonium acetate, 1 mM EDTA). The molar concentration of oligonucleotides
was calculated by determining the optical density at 260 nm and molar extinction
coefficient for each oligonucleotide. Oligonucleotides were end labeled for hy-
bridization experiments, using 8 U of polynucleotide kinase (Boehringer Mann-
heim), 5 ml of [g-32P]ATP (50 mCi/ml; NEN/Dupont), and 10 pmol of oligonu-
cleotide in a 20-ml reaction mixture for 1 h at 378C. Labeled oligonucleotides
were subsequently purified from reaction mixtures by G-25 spin column chro-
matography (Boehringer Mannheim). Oligonucleotides were designed to be
complementary to the coding strand of the UL93 through UL99 region of the
HCMV genome on the basis of the complete genomic sequence for HCMV
(AD169) determined by Chee et al. (14). All computer sequence analysis was
carried out by using the Genetics Computer Group program (32).
RNA isolation and Northern (RNA) blot analysis. At each time point, poly-
adenylated RNA was isolated from approximately 107 HELs (one T150 flask)
infected with HCMV (Towne) at a multiplicity of approximately 10 or mock
infected, using the polyAttract mRNA isolation system (Promega) or MicroFast-
Tract system (Invitrogen). RNA samples were standardized by using several
techniques, including (i) spectrophotometric quantitation (optical density at 260
nm), (ii) ethidium bromide staining of RNA gels following size fractionation, and
(iii) hybridization of Northern blots with internal standard probes.
Northern blots were prepared by size fractionating mRNA on denaturing
agarose gels as described previously (5), followed by an overnight transfer to a
nitrocellulose membrane (MSI). Blots were prehybridized for at least 2 h at 378C
in oligonucleotide prehybridization buffer (63 SSC [13 SSC is 0.15 M NaCl plus
0.015 M sodium citrate], 0.05% sodium pyrophosphate, 53 Denhardt’s reagent,
0.1% sodium dodecyl sulfate, 100 mg of salmon sperm DNA per ml, 100 mg of
yeast RNA per ml) and hybridized overnight at 378C in oligonucleotide hybrid-
ization buffer (63 SSC, 0.05% sodium pyrophosphate, 13 Denhardt’s reagent,
100 mg of yeast RNA per ml, 5 3 106 to 1 3 107 cpm of each end-labeled
oligonucleotide listed in Table 1 per ml). Blots were washed two to four times for
5 min at room temperature in 63 SSC–0.05% sodium pyrophosphate and once
at 658C for 15 min in 63 SSC–0.05% sodium pyrophosphate, as needed. Blots
were subsequently autoradiographed for 12 h to 3 days at 2708C, using Cronex
intensifying screens. For most experiments, blots were successively reprobed with
different oligonucleotides by stripping blots with 70% formamide for 30 min at
378C and subjecting them to a 20-min wash in 0.13 SSC at room temperature.
Blots were confirmed to be stripped by demonstrating a complete lack of signal
upon overnight autoradiography at2708C. Northern hybridizations shown in this
report are representative of results obtained in at least three repetitions using
independently isolated RNA samples.
Primer extension. Primer extension mapping of the 59 ends of some RNAs was
carried out essentially as described previously (5), using RNA purified from
HCMV- or mock-infected HELs (one T150 flask per time point). The sequences
for oligonucleotides used in primer extensions are shown in Table 1. Extended
products were size fractionated on polyacrylamide-urea sequencing gels (5); gels
were fixed for 20 min in 10% methanol–7% acetic acid, dried, and autoradio-
graphed overnight at 2708C, using Cronex (Dupont) intensifying screens. The
sizes of extended products were determined by comparing band mobilities
against an M13 sequencing ladder generated by using the reagents, single-
stranded DNA, and primer supplied with the Sequenase (United States Bio-
chemical) DNA sequencing kit.
RNase protection assays. RNase protection was carried out essentially as
described previously (5). Single-stranded RNA probes were generated from
linearized plasmids with T7, SP6, and T3 RNA polymerase sites containing
HCMV (Towne) genomic subclones (described above). Riboprobes were gen-
erated by using reagents supplied with the Riboprobe kit (Promega) and
[a-32P]CTP (10 mCi/ml; Amersham) as suggested by the manufacturer. Labeled
probes were separated from unincorporated nucleotides by G-50 spin column
chromatography (Boehringer Mannheim). Labeled probe (105 cpm) was hybrid-
ized overnight at 458C with 10 mg of whole cell RNA purified from mock-infected
or 72-h-postinfection (hpi) infected cells as described above. In some experi-
ments, 10 mg of yeast tRNA (Boehringer Mannheim) was also used as a negative
control. RNA hybrids were digested with 40 mg of RNase A per ml plus 2 mg of
RNase T1 per ml for 60 min at 308C and then subjected to a 15-min digestion
TABLE 1. Sequences of oligonucleotides used in this study
Oligo-
nucleotide Sequence
UL99-1 .........GGA CAG GTA AAT TGA GGT GTC CTC TTC GTC
PolyA-1.........CTG TTC TTC CAC CAG CTA CTT TAC GTG
PolyA-2.........GCG AAG AAG AGG ACG ACG ACG ATG ATG AAG
PolyA-3.........CTT CAT CAT CGT CGT CGT CCT CTT CTT CGC
UL98-1 .........AAG CCC TCG TGT TTG ATA CCG AAC TGG ATG
UL98-2 .........TCG TAG TCC AAA CTC GAG ACG CCC CAC ATG
UL97-1 .........GAT GAT CTG GTC GTT GGA ACA GGT GCA ATG
UL97-2C ......ATA GTG GCG ACA GTC TTC CCT GTT CCT AGA G
UL96-1 .........GTG TCC TTC AGC TCG GTT AAA GAG TCC AGC
UL96-2 .........GAT GCT GCT GCT GCT CAA GGT CGA CGC GC
UL95-1 .........ATT GCG TAA CGC ATA ATC ACG CAC ACA AAG
UL95-2 .........GAT CCG CAG TTT CAG CAG ATC AAC AAC TTC
UL94-1 .........AAC CTA CGG CGC CAT AGG TAC TTG GCG TCA T
UL94-3 .........CAC CAC GTC AGC GTA CCA AGT CTG TTC
UL93-1 .........CGC CAG ATC CGA ATA CAG GTG CGT TTC C
UL92-1 .........AAC TGG ATC TCC TCG GTA AAC GCG TTC TGG
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with proteinase K, phenol-chloroform extraction, and ethanol precipitation.
Products were separated on denaturing polyacrylamide-urea gels; the gels were
subsequently dried and subjected to autoradiography. Sizes of protected frag-
ments were estimated in comparison with a radiolabeled single-stranded DNA
ladder (Bethesda Research Laboratories). In our hands, RNA products had
mobilities approximately 5 to 15% higher than those of the single-stranded DNA
markers.
RESULTS
Analysis of RNA transcribed from the UL93 through UL99
region. HCMV ORFs UL93 through UL99 are located within
the long unique region of the viral genome spanning bp 134043
to 145801 (Fig. 1). Previous studies indicated that HCMV
ORF UL99 is transcribed on two 39-coterminal transcripts of
1.3 and 1.6 kb which terminate at a consensus polyadenylation
signal located immediately downstream of UL99 (45, 46, 52,
53, 55, 56). The smaller message encodes the 28-kDa virion
phosphoprotein (UL99), while the 1.6-kb message encodes a
58-kDa frameshift variant of UL99 (UL99A). These studies
and others (25) also demonstrated that a series of larger-
molecular-weight transcripts hybridized with UL99-specific
probes; however, the nature of these transcripts was not inves-
tigated. To determine the exact number and sizes of the larger-
molecular-weight transcripts, Northern blots of polyadenylated
RNA isolated from HCMV-infected HELs at immediate-early
(5 hpi), early (24 hpi), and late (72 hpi) times of infection, as
well as mock-infected-cell RNA, were probed with an end-
labeled oligonucleotide internal and specific to UL99 coding
sequences. The results of this experiment (Fig. 2) indicated
that, in addition to the 1.6- and 1.3-kb transcripts, a series of
seven larger transcripts having molecular sizes of approxi-
mately 10.5, 9.1, 7.3, 5.6, 4.7, 3.5, and 2.6 kb hybridized with the
UL99-specific oligonucleotide. All of the transcripts were max-
imal at 72 hpi; in addition, the 7.3-, 5.6-, 4.7-, and 2.6-kb
transcripts were detected as early as 5 hpi (also see Fig. 4 for
a longer exposure of 5-hpi transcripts, which more clearly dem-
onstrates the presence of the four transcripts). Since an oligo-
nucleotide probe was used in this analysis, our results indicate
that all of the transcripts arise from the same strand of the viral
DNA as the 1.6- and 1.3-kb UL99-specific transcripts.
To determine the potential coding capacity of the 10.5- to
2.6-kB transcripts, Northern blots of mock-infected-cell and
infected-cell RNA were subsequently probed with a series of
oligonucleotide probes specific for predicted ORFs proximal
to UL99 and encoded from the same strand of the viral ge-
nome. Within 11 kb upstream of UL99, there are six putative
ORFs colinear with UL99 (UL98, UL97, UL96, UL95, UL94,
and UL93), and probes for all of these ORFs were used (see
Table 1 for probe sequences). The hybridization pattern seen
in these experiments (Fig. 3) is indicative of a series of over-
lapping, 39-coterminal transcripts containing coding sequences
for ORFs UL98 through UL93. These messages appeared with
kinetics identical to those of the identically sized transcripts
shown in Fig. 2; therefore, only the 72-hpi time point is shown
in Fig. 3. The 10.5-kb message hybridized to all probes specific
for UL98 through UL93 (lanes 1 to 6) but did not hybridize to
a probe specific for UL92 (lane 7), indicating that UL93 de-
fines the upstream boundary for this series of transcripts. In
addition, it would appear that the upstream boundaries for the
9.1-, 7.3-, 5.6-, 4.7-, and 2.6-kb messages are UL94, UL95,
UL96, UL97, and UL98, respectively, since in each case,
probes to the next most proximal upstream ORF failed to
hybridize to the smallest message detected with the prior
probe.
The UL96-specific probe appeared to hybridize slightly with
an approximately 4.2- to 4.7-kb band (Fig. 3, lane 3); however,
detailed RNA mapping by RNase protection (see below) did
not detect any initiation or splice sites within ORF UL96
consistent with a message of this size. More likely, the UL96
probe cross-hybridized with contaminating rRNA in the polya-
denylated RNA preparations; in support of this idea, we could
also detect an approximately 4.7-kb transcript in mock-infect-
ed-cell RNA with the UL96 probe but not with probes to UL97
to UL99, which also detected a 4.7-kb band (Fig. 2 and data
not shown). Several smaller transcripts were also weakly de-
tected with probes to UL97 in some experiments (lane 2);
however, we could not consistently detect these transcripts
with either oligonucleotide or double-stranded DNA probes
(data not shown). Thus, it is likely that the UL97 oligonucle-
otide cross-reacted with several small, unrelated viral or cellu-
lar transcripts. More detailed RNA mapping (presented be-
low) supported this conclusion. The 3.5-kb message was
detected only with the UL99-specific probe; in addition, this
transcript was not detected with an oligonucleotide probe
(polyA-1) specific for 39 untranslated sequences found in the
UL99 transcripts (lane 8). This result suggested that the 3.5-kb
message is an unrelated viral or cellular transcript containing
some sequence homology to UL99. Probe polyA-2 located
downstream of the UL99 polyadenylation site did not detect
the UL99 family of messages (lane 9); however, a probe to the
opposite strand of the viral DNA (polyA-2) detected several
unrelated transcripts originating from the opposite strand of
the viral DNA (not shown), indicating that reaction conditions
FIG. 1. Schematic representation of the HCMV (Towne) genome in stan-
dard configuration showing the locations of ORFs UL93 through UL99. (A)
Unit-length map; (B) EcoRI map as described elsewhere (25); (C) subfragment
of the HCMV genome containing ORFs UL93 through UL99 encompassing
sequences from nt 134043 to 145801 (14), showing locations of restriction sites
(P, PstI; E, EcoRI; X, XhoI; K, KpnI) and a polyadenylation signal (PA;
AATAAA).
FIG. 2. Northern blot analysis of polyadenylated RNA from mock-infected
(lane M) and infected HELs at the times indicated (hours postinfection), probed
with end-labeled oligonucleotide UL99-1, specific for ORF UL99. Approximate
sizes are shown in kilobases. Photoimages of autoradiographs shown in this
report were captured by using NIH Gel Capture 2.0 for Macintosh (National
Institutes of Health). Figures were constructed by using MacDraw 2.0 (Claris)
for Macintosh and CorelDraw! 3.0 (Corel Corp.) for IBM-compatible personal
computers.
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were sufficient to detect any hybridization to polyA-2. This
result suggests that the UL99-proximal polyadenylation signal
defines the 39 boundary for all of the transcripts overlapping
UL99 and is consistent with the preceding Northern blots,
which indicate that the larger messages initiate upstream of
UL99. These results are also consistent with previous studies
which mapped the 39 termini of the 1.3- and 1.6-kb UL99
transcripts (52, 53, 55, 56).
In addition to the UL99 family of transcripts, probes to
UL92, UL93, and UL94 (Fig. 3, lanes 5 and 6) detected tran-
scripts of approximately 5.0 and 4.4 kb (probes UL92, UL93,
and UL94) as well as a 2.0-kb transcript which did not conform
to the colinear, 39-coterminal arrangement described above.
Preliminary characterization of these transcripts suggests that
they are members of a second family of overlapping transcripts
which utilize a second polyadenylation signal located immedi-
ately downstream of UL94. This polyadenylation signal, on the
basis of its primary sequence, is predicted to be less efficient
than the UL99 polyadenylation signal (data not shown), which
probably accounts for the appearance of the 10.5- and 9.1-kb
messages. Whatever the case may be, it is clear that the smaller
UL93- and UL94-specific transcripts represent novel species
which do not terminate 39 coterminal with the UL99 family of
transcripts. These transcripts are likely to be specific for pro-
teins encoded from open reading frames UL91 through UL94,
and experiments are in progress to confirm this hypothesis.
Assignment of the UL99 3*-coterminal transcripts to kinetic
classes. To define the kinetic classes of the larger UL99-co-
terminal transcripts, polyadenylated RNA was isolated from
HCMV-infected cells at 5 hpi in the presence of cycloheximide
and at 72 hpi in the presence of ganciclovir (DHPG), as well as
at both time points in the absence of drugs. The results shown
in Fig. 4 were obtained by using UL98-specific probe UL98-1
(Table 1), which detects all of the novel UL99 39-coterminal
messages described above. Hybridizations with probes to read-
ing frames UL93 through UL97 yielded similar results (data
not shown). Figure 4 indicates that none of the messages are
transcribed in the presence of cycloheximide at 5 hpi (lane 3),
suggesting that there are no immediate-early transcripts in this
family. In the presence of DHPG at 72 hpi, however, the 10.5-
and 9.1-kb messages are not transcribed (lane 4), indicating
that these messages are of a late classification. Levels of the
4.7-kb transcript appear to be unaltered by DHPG treatment
(lane 4), implying that this transcript is of an early classifica-
tion. The 7.3-, 5.6-, and 2.6-kb messages are transcribed, albeit
at reduced levels, in the presence of DHPG (lane 4), indicating
that these are early or early-late transcripts. Interestingly, the
levels of the 5.6- and 2.6-kb messages are significantly higher at
FIG. 3. (A) Composite Northern blot analysis of polyadenylated RNA isolated from 72-hpi infected fibroblasts and probed with oligonucleotide probes UL98-1
(lane 1), UL97-1 (lane 2), UL96-1 (lane 3), UL95-1 (lane 4), UL94-1 (lane 5), UL93-1 (lane 6), UL92-1 (lane 7), polyA-1 (lane 8), and polyA-2 (lane 9). (B) Schematic
representation of ORFs UL93 through UL99 and the downstream polyadenylation signal; numbers indicate relative positions of probes used in panel A and proposed
structures for UL99 coterminal transcripts; sizes of transcripts given at the right in kilobases.
FIG. 4. Northern blot analysis of polyadenylated RNA from HCMV-infected
HELs at 5 hpi (lane 1), 72 hpi (lane 2), 5 hpi with cyclohixamide (CHX; 50 mg/ml;
lane 3), and 72 hpi with DHPG (10 mM; lane 4) probed with end-labeled
oligonucleotide UL98-1. Sizes are indicated in kilobases.
1524 WING AND HUANG J. VIROL.
5 hpi than at 72 hpi in the presence of DHPG (lanes 1 and 4);
this result suggests that these messages may be under the
control of multiple promoter elements allowing expression in
more than one kinetic class. This phenomenon has been ob-
served in the transcriptional control of other HCMV gene
products (12, 34, 47, 48).
Mapping the 5* ends of novel UL99 family transcripts by
primer extension. Mapping of the 10.5- to 2.6-kb messages by
Northern hybridization suggested that they were transcribed in
a colinear arrangement and that each message initiated up-
stream of a different ORF. To confirm this observation, we
mapped transcription cap sites upstream of each of ORFs
UL93 through UL98 by using a combination of primer exten-
sion and RNase protection assays. Figure 5 shows the results of
primer extensions using probes proximal to UL98, UL94, and
UL95. In Fig. 5A, an end-labeled oligonucleotide probe over-
lapping the predicted translational start site for UL98 was
hybridized with RNA from mock-infected and 72-hpi infected-
cell RNA and extended with Moloney murine leukemia virus
reverse transcriptase as outlined in Material and Methods. The
results indicate that an infected-cell-specific transcript initiates
177 nucleotides (nt) upstream of the UL98 initiation codon;
this site is also 25 nt downstream of a consensus TATA ele-
ment, indicating that it is a favorable start site for transcription.
In addition, the size of an unspliced transcript originating at
this site and extending to the UL99 polyadenylation site is
approximately 2,639 nt; this correlates well with the estimated
size of the transcript shown in by Northern hybridization to
initiate between the UL97 and UL98 probes (2.6 kb). Analysis
of the genomic sequence upstream of the TATA box indicated
the presence of a consensus CREB/ATF site (59TACGTCA
G39) at 282, relative to the RNA initiation site, as well as an
E2F site (59TTTCGCCG39) at 2127 and a serum response
element (59GATGTCC39) at position 2152. All of these ele-
ments have been identified in other HCMV transcription units
(24, 29, 36, 38, 43, 51, 63). CREB/ATF binding sites appear to
play a role in activation of the major immediate-early enhancer
mediated through the viral pp71 (UL82) gene product (51).
CREB/ATF sites are also found upstream of the HCMV DNA
polymerase (a viral early gene product) as well as the UL112-
UL113 early gene products (41, 64). In addition, E2F sites are
found upstream of several viral early transcription units (36,
43, 44, 64, 82). Since the protein product of ORF UL98 is
thought to encode another enzyme involved in viral DNA
replication or nucleotide metabolism (an alkaline DNase), it
too is likely to be expressed at early times of infection; this
possibility is supported by the appearance of the cyclohexim-
ide-sensitive 2.6-kb transcript by 5 hpi.
To map cap sites upstream of UL94, we used an oligonucle-
otide probe (UL94-3; Table 1) located approximately 200 nt
upstream of the predicted translational start site for this ORF,
since preliminary Northern hybridizations indicated that a
larger 59 untranslated region was likely to be seen in messages
initiating upstream of UL94. The oligonucleotide probes used
for primer extension hybridized in Northern blots with identi-
cally sized transcripts as probes internal to the UL94 reading
frame, and no extended products were detected with more
downstream probes (data not shown). Figure 5B indicates that
a transcripts initiating 127 nt upstream of the UL94 probe
could be detected after hybridization of end-labeled UL94-3 to
72-hpi infected-cell RNA and extension with reverse tran-
scriptase; no extended products were detected with mock-in-
fected RNA. This cap site is approximately 300 nt upstream of
the predicted initiation codon for UL94. The mapped cap site
was also found 30 nt downstream of a consensus TATA ele-
ment (Fig. 5D). This cap site is in agreement with the Northern
hybridization data in Fig. 3, which suggest that the 59 end of the
9.1-kb message is located between UL93 and UL94. Further-
more, the size of an unspliced transcript extending from this
start site to the UL99 polyadenylation site is 9,120 nt; again,
these results are in agreement with the Northern hybridization
data. Analysis of the genomic sequence proximal to the UL94
TATA box indicated the presence of consensus binding sites
for Sp1 (59GGGCGG39), CREB/ATF (59CGTCA39), NF-kB
(59GGGAACTTT39), and p53 (59GAACATGTCC39) at 258,
286, 297, and 2120 relative to the RNA initiation site, indi-
cating that the control of expression from this promoter could
be quite complex. Since the 9.1-kb message appears only at late
times of infection and is sensitive to treatment with DHPG, the
UL94 protein is likely to be a late viral gene product. The
mechanisms regulating expression of late gene products are
unclear, but it is possible that cellular factors such as those
mentioned above contribute in part to this regulation.
To map RNA cap sites upstream of UL95, we used an
oligonucleotide which hybridized with sequences located 352
nt upstream of the predicted initiation codon for UL95
(UL95-2; Table 1). This oligonucleotide hybridized with iden-
tically sized products as internal UL95 probes in Northern
blots (data not shown). Following hybridization of end-labeled
UL95-2 with RNA from mock-infected and 72-hpi infected
cells and extension with reverse transcriptase, we were able to
detect an extended product of 121 nt specifically with infected-
cell RNA (Fig. 5C). Transcripts initiating at this site and ex-
tending to the UL99 polyadenylation site would be 7,232 nt in
length, which is in agreement with the 7.3-kb size of transcripts
shown by Northern hybridization to initiate between UL95 and
UL94 probes. Analysis of the genomic sequence proximal to
this initiation site indicates the presence of a consensus TATA
box at 228 with respect to the initiation site, as well as con-
sensus CREB/ATF (59TTGGTCA39 and GTGACGTCG39)
and serum response element (59GATGTCG39) sites at 239,
2166, and 2124, respectively. The 7.3-kb message is detected
at weak levels by 5 hpi and accumulates to higher levels by 24
hpi; thus, regulation of its expression as an early gene product
could be mediated in part through the CREB/ATF sites, as has
been postulated for the viral DNA polymerase and UL112-
UL113 gene products (41, 64).
Analysis of UL99 family transcripts by RNase protection.
RNase protection assays were used to map transcripts initiat-
ing proximal to ORFs UL96, UL97, and UL93, since high GC
content in these regions yielded high background with primer
extensions (data not shown); the UL98-proximal cap site was
also mapped by RNase protection. Figures 6 and 7 show the
results of this set of experiments. To map transcripts proximal
to UL96 and UL97, we subcloned a series of overlapping
HCMV genomic fragments spanning a 2-kb region inclusive of
partial UL95, UL96, and UL97 coding sequences (Figure 6F).
These genomic fragments were used to generate a series of
riboprobes which were hybridized to RNA from mock-infected
and 72-hpi infected cells, digested with RNase, and analyzed
on sequencing gels as described in Materials and Methods.
Figures 6A and B show the results of experiments obtained
with riboprobes generated from plasmid p7z97P, which con-
tains a 1,051-bp insert spanning sequences 513 bp upstream of
the predicted UL96 initiation codon to 67 bp within ORF
UL97. When digested with SalI, this plasmid generated a
210-nt antisense probe initiating 67 nt within ORF UL97 and
extending to 78 nt upstream of the UL97 initiation codon.
Figure 6A indicates that a protected product of approximately
134 nt was obtained with SalI-digested p7z97P riboprobe. The
size of this product is consistent with a transcript initiation or
splice site located approximately 57 to 77 nt upstream of the
VOL. 69, 1995 TRANSCRIPTION OF HCMV ORFs UL93 THROUGH UL99 1525
predicted UL97 initiation codon. Figure 6B indicates that a
similarly sized product (154 nt) was obtained with full-length
1,051-nt p7z97P probe digested with EcoRI; the approximately
20-nt difference seen between the two probes is due to slight
differences in gel conditions which result in sequence-depen-
dent 5 to 15% differences in the mobilities of RNA products
with respect to the single-stranded DNA size markers. In ad-
dition, the product at approximately 330 nt is likely to be due
to either incomplete digestion or a nonspecific interaction and
was not detected in further RNase protection analysis (de-
scribed below). We also detected complete protection of
p7z97P subfragment p97Sal-2 in RNase protection assays of
infected-cell RNA (Fig. 6C). The small shift in mobility seen
with this probe is due to the presence of approximately 50 nt of
vector sequence at the ends of the probe. Analysis of the
genomic sequence in the vicinity of this site indicates the pres-
ence of a consensus TATA element located at approximately
226 with respect to the initiation site, as well as a consensus
CREB/ATF site (59CGTCA39) at 248 and an E2F site (59TT
TCGGCG39) at 279. The size of an unspliced transcript ini-
tiating at this site and extending to the UL99 polyadenylation
signal would be approximately 4,714 nt, which is in agreement
with the 4.7-kb band seen in Northern hybridizations. This
transcript was shown to exhibit early kinetics with respect to its
expression during viral infection. Since ORF UL97 is thought
to encode a ganciclovir kinase (50, 71), it is likely to be involved
in nucleotide metabolism and thus would be expected to be
expressed at early times of infection.
To examine transcriptional initiation proximal to the UL96
start site, probes p97ES-1 and pBSUL95P were used (Fig. 6D
and E). BglII-digested p97ES-1 allowed generation of a 245-nt
riboprobe which overlaps the first 12 nt of ORF UL96 and
extends upstream. As seen in Fig. 6D, this probe was fully
protected from RNase digestion when hybridized to infected-
cell RNA, but not mock-infected-cell RNA, except for vector
sequences located at the 59 end of the probe. This result is
consistent with those obtained with full-length p7z97P probe
(see above), which entirely overlaps the p97ES-1 BglII probe.
With SalI-digested pBSUL95P, a 445-nt probe extending into
UL95 coding sequences was generated. This probe produced
three major bands in RNase protection of infected-cell RNA
of approximately 140, 145, and 280 nt. Analysis of the genomic
FIG. 5. Primer extension analysis of RNA initiating upstream of ORFs UL98, UL94, and UL95. (A) Primer extension results with oligonucleotide UL98-2
hybridized to whole cell RNA isolated at 72 hpi (lane 72) or mock infected (lane M) and M13 sequence ladder (A, C, G, T; lane M13); (B) primer extension with
oligonucleotide UL94-3 hybridized to RNA isolated at 72 hpi (lane 72) or mock infected (lane M) and M13 sequence ladder (lane M13); (C) primer extension with
end-labeled oligonucleotide UL95-2 hybridized to RNA isolated at 72 hpi (lane 72) or mock-infected (lane M) and M13 sequence ladder (lane M13). (D) Sequences
of probes used. Sizes are indicated in nucleotides.
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sequence in this region showed no obvious splice sites proximal
to these sites and no consensus TATA boxes. However, con-
sensus sites for the cellular transcription factors E2F (59TTT
TGCGCG39) and Sp1 (59CCGCGC39) spaced 10 bases apart
were detected within 18 bases of the sites mapped by the 140-
and 145-nt protected fragments. Additionally, a consensus ad-
enovirus major late transcription factor (MLTF) binding site
(59TCACGTGG39) was located approximately 10 bases up-
stream of the site mapped by the 280-nt fragment. Both E2F
and Sp1 have been demonstrated to direct initiation of tran-
scription from cellular TATA-less promoters (10, 11, 61, 72),
and an MLTF binding site is thought to play a crucial role in
activation of the HCMV b2.7 transcript (44). Thus, it is likely
that these factors play some role in activation of transcription
from the UL96 promoter and that the 5.6-kb transcript ob-
served in Northern hybridizations represents a class of tran-
scripts initiating at three distinct sites. It is also worth noting
that the 5.6-kb transcripts accumulate to high levels by 5 hpi,
consistent with their classification as early messages.
To map potential cap sites upstream of UL93, a 562-nt
riboprobe generated from EcoRI-cut p93S1-10 was used (Fig.
7C). This probe specifically protected a fragment of approxi-
mately 160 nt when hybridized to RNA from 72-hpi infected
cells (Fig. 7A). The size of the protected fragment is consistent
with a cap site 80 nt upstream of the predicted UL93 transla-
tional start site. Analysis of the genomic sequence in the vicin-
ity of this site indicates that a TATA-like (59TATTTA39) ele-
ment is located 31 nt upstream of the mapped cap site. In
addition, two potential CREB/ATF sites are located at 2127
(59TACCTCAT39) and 2254 (59CGTCA39). In all, five of the
six putative promoters mapped in this study contain putative
ATF elements, the exception being the apparently TATA-less
UL96 promoter. Thus, it is possible that CREB binding rep-
resents an important control mechanism regulating HCMV
gene expression.
To confirm the cap site mapped by primer extension up-
stream of UL98, RNase protection was performed with a
502-nt riboprobe generated from FspI-cut p7zXS (Fig. 7C).
This probe overlaps the putative UL98 start site by 17 bases
and extends upstream relative to this position. When this
probe was hybridized to 72-hpi infected-cell RNA, a protected
fragment of approximately 200 nt was detected (Fig. 7B). No
FIG. 6. RNase protection analysis of RNA initiating proximal to ORFs UL96 and UL97. Riboprobes used were SalI-digested p7z97p (A), EcoRI-digested p7z97p
(B),HindIII-digested p97Sal2 (C), BglII-digested p97ES1 (D), and SalI-digested pBSUL95P (E). (A to D) Lanes: 1, unreacted riboprobe (R); 2, RNase protection using
72-hpi infected-cell RNA (protected products designated P); 3, RNase protection using mock-infected-cell RNA; 4, end-labeled single-stranded DNA ladder markers
(sizes shown in nucleotides). (E) Lanes: 1, RNase protection using 72-hpi infected-cell RNA; 2, RNase protection with mock-infected-cell RNA; 3, unreacted free
probe; lane 4, DNA ladder (sizes shown in nucleotides). (F) Schematic diagram of the UL96 to UL97 genomic region showing the relative position of each probe used
as well as relative locations of putative promoter elements (MLTF, Sp1, E2F, and TATA); also shown are the transcripts mapped by this analysis showing regions of
each RNA mapped by the probes in panels A to E.
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protection was observed with either mock-infected-cell RNA
or tRNA controls. The 200-nt fragment places the RNA initi-
ation site at approximately the same position which was
mapped by primer extension, confirming this result as well as
results obtained by differential hybridization and genomic se-
quence analysis. As mentioned above, we were able to detect
consensus ATF, E2F, and serum response elements proximal
to the TATA box in the UL98 promoter.
DISCUSSION
In this report, we provide evidence for the existence of a
large family of overlapping mRNAs transcribed from the
unique long region of the HCMV genome, encompassing
ORFs UL93 through UL99. A summary of the proposed struc-
tures for these transcripts is shown in Fig. 3. The smallest two
messages, having sizes of 1.3 and 1.6 kb, have previously been
shown to have the capacity to encode ORFs UL99 and UL99A
(45, 46, 52, 53, 55, 56). The other messages, having sizes of 2.6,
5.6, 7.3, 9.1, and 10.5 kb, are shown in this report to be 39
coterminal with the UL99 messages and to have the capacity to
encode ORFs UL93 through UL98. Using primer extension
and RNase protection analysis, we have mapped the transcrip-
tion initiation sites for the 2.6- to 10.5-kb messages; each of the
messages except for the 5.6-kb transcript appears to initiate
from a TATA-containing promoter, on the basis of the pres-
ence of consensus TATA elements in the genomic sequence 20
FIG. 7. RNase protection analysis of RNA initiating proximal to ORFs UL93 and UL98 mapped with riboprobes generated from EcoRI-digested p93S1-10 (A) and
FspI-digested p7zXS (B). Lanes: 1, 72-hpi infected-cell RNA; 2, mock-infected-cell RNA; 3, unreacted probe; lane 4, end-labeled single-stranded DNA ladder (sizes
shown in nucleotides). (C) Schematic representation of the RNase protection showing genomic positions of ORFs and putative promoter elements, protected regions
of transcripts mapped in this study, and riboprobes used to map transcripts.
1528 WING AND HUANG J. VIROL.
to 30 bases upstream of the mapped initiation sites. The 5.6-kb
transcript appears to initiate from TATA-less promoters; how-
ever, there are consensus E2F, Sp1, and MLTF sites in favor-
able positions upstream from the mapped 59 start sites which
could direct the initiation of these transcripts. E2F and Sp1
have both been demonstrated to direct activation of transcrip-
tion from cellular TATA-less promoters (10, 11, 61, 72). In-
terestingly, many cellular promoters containing E2F sites con-
trol the expression of gene products required for DNA
replication, such as dihydrofolate reductase (10, 11, 61, 72), as
well as genes involved in cell cycle control, such as c-myc (74).
An S-phase-specific complex containing E2F, cyclin A, p33cdk2,
and p107 has been shown to be induced at early times of
HCMV infection of fibroblasts (76), and cellular E2F-respon-
sive genes such as the dihydrofolate reductase, DNA poly-
merase a, and topoisomerase II genes are also known to be
induced by HCMV infection (9, 28, 37, 39). Additionally, at
least three families of HCMV early gene products have E2F-
like sites in their promoters, including the 2.2- and 2.7-kb early
transcription units (43, 44, 65) and the UL84 gene product (34,
36). The protein product of ORF UL84 has recently been
shown to be required for viral DNA replication (57), thus
establishing a possible link between E2F, HCMV early gene
expression, and viral DNA replication. This effect is likely to be
mediated through the HCMV IE72 and IE86 gene products,
potentially in a manner analogous to the adenovirus E1A and
E1B proteins, since cotransfection experiments demonstrate
IE72 and IE86 responsiveness of viral early promoters. The
5.6-kb transcripts are also transcribed at early times of infec-
tion, and it is possible that proteins translated from this family
of messages are also involved in viral DNA replication.
The 2.6- and 4.7-kb messages initiating upstream of UL98
and UL97, respectively, also contain putative E2F sites, and it
is possible that these gene products are also involved in viral
DNA replication. Since the promoters for both of these tran-
scripts appear to contain TATA boxes, their mode of regula-
tion is probably distinct from that of the 5.6-kb transcripts.
Indeed, the 4.7-kb transcript appears to exhibit true early ki-
netics, since it is present at early times of infection, is sensitive
to cycloheximide treatment, and is unaffected by the absence of
viral DNA replication. The 2.6-kb message exhibits early-late
kinetics similar to that of the 5.6-kb family, in that it is present
at early times of infection, is sensitive to cycloheximide treat-
ment, and requires viral DNA replication for maximal expres-
sion at late times of infection. Other HCMV transcription units
exhibiting similar dual kinetics have been well documented
(12, 47, 48). The protein product of ORF UL97 has recently
been shown to encode a putative ganciclovir kinase activity (50,
71), and the UL98 gene has homology to the herpes simplex
virus alkaline DNase (14, 18, 27). Both of these gene products
are also highly conserved in all of the human herpesviruses as
well as in equine herpesvirus and herpesvirus saimiri (13–15,
18, 21, 26, 27, 58, 62). The UL97 and UL98 homologs in other
herpesviruses are also transcribed as a series of overlapping
messages reminiscent of what is seen with HCMV (18, 26, 27);
thus, the acquisition of these ORFs appears to have occurred
early in the evolution of the herpesviruses, and their mainte-
nance throughout the divergence of the herpesviruses suggests
that they are involved in shared aspects of herpesvirus biology.
It should be pointed out, however, that none of the ORFs in
this family appear to be essential for viral DNA replication in
permissive fibroblasts (57); thus, what role they might play in
DNA replication is unclear. Also, it is unlikely that E2F re-
sponsiveness is the sole determinant controlling HCMV early
gene expression, since not all early promoters contain E2F
sites. Rather, E2F responsiveness probably provides one con-
venient mechanism by which high levels of viral gene products
needed for viral DNA replication can be maintained at an
appropriate point during the replicative cycle. Other mecha-
nisms besides E2F responsiveness are certain to exist.
The 7.3-kb transcript also appears to exhibit early-late ex-
pression, since it is transcribed at early times of infection, is
sensitive to cycloheximide treatment, and is partially depen-
dent upon viral DNA replication. The putative promoter for
the 7.3-kb transcript contains ATF/CRE elements as well as a
serum response element. All of the TATA-containing promot-
ers mapped in this study contain consensus CRE elements,
suggesting that CREB binding could play an important role in
regulating gene expression from these promoters. CREB bind-
ing sites have been shown to be located in the promoters of
several other viral gene products (38, 51, 63). Interestingly, the
recently cloned CREB-associated protein CBP has sequence
homology with the E1A-associated p300 protein (4), which is
itself a TFIID adaptor protein (27a). Since the activity of these
factors is cell cycle regulated, it is possible that S-phase induc-
tion by HCMV (1, 76) could lead to expression of the inducible
CREB-binding activity and the subsequent activation of
HCMV promoters with ATF elements.
The 9.1- and 10.5-kb transcripts appear only at late times of
infection, and their expression is completely abolished in the
absence of viral DNA replication, suggesting that these are
true late transcripts. These transcripts are likely to encode
ORFs UL94 and UL93, respectively, on the basis of the posi-
tions of their cap sites. Indeed, the protein product of ORF
UL94 is found in infected cells only at late times of infection
(81b). UL94 and UL93 coding sequences are also found on a
series of smaller, overlapping transcripts which appear to de-
fine a novel transcription unit. No precursor-product relation-
ship between the larger and smaller messages is evident, how-
ever. Rather, it is more likely that the smaller messages utilize
a second polyadenylation site located in the genomic sequence
immediately downstream of UL94. Transcripts initiating up-
stream of UL94 at the site mapped in this study and terminat-
ing at this upstream polyadenylation signal would be approxi-
mately 2.0 kb in size, which is consistent with the 2.0-kb
transcript seen with UL94 probes. Interestingly, the putative
promoters upstream of UL93 and UL94 appear to be quite
complex in that both sequences contain consensus binding sites
for a variety of cellular factors, including NF-kB, Sp1, ATF,
MLTF, and p53. Deletion analysis of the UL99/UL99A (an-
other HCMV late gene) promoter did not indicate a depen-
dence on sequences containing any of these binding sites (25).
Thus, it is not yet clear whether these factors are required for
UL93 and UL94 transcription. We are particularly intrigued by
the consensus p53 binding site in the putative UL94 promoter,
though, since only a very small number of these sites are found
within the HCMV genome (81a). The UL94 gene product is
highly conserved in the other human herpesviruses; the herpes
simplex virus homolog of UL94 (UL16) was recently shown to
be nonessential for productive viral infection in tissue culture
(6, 7).
The pattern of translation which occurs from the UL99 fam-
ily of transcripts is subject to speculation at present; however,
since cap sites for each of the transcripts are located immedi-
ately upstream of different ORFs, it is likely that the first ATG
encountered determines which protein product is translated
from a given message (42). We cannot rule out the possibility
that small splicing events which delete sequences for down-
stream reading frames are present in the mature transcripts,
since the transcripts were not mapped contiguously by using
overlapping probes spanning the entire UL93 to UL99 region;
however, this is highly unlikely since the sizes of the transcripts
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described in this report are consistent with sizes of unspliced
transcripts initiating at the mapped cap sites and extending to
the UL99 polyadenylation signal, and detailed mapping of the
UL96 to UL97 region did not detect any splicing events. Struc-
turally, the appearance of unspliced, overlapping transcripts
utilizing a common polyadenylation signal and encoding dis-
tinct viral proteins has been documented for other HCMV
transcription units (34, 60, 79). Additionally, it is possible that
multiple reading frames are translated from the apparently
polycistronic transcripts; however, coding sequences for the
UL99 gene product (pp28) are found on all of the 2.6- to
10.5-kb messages, as shown by Northern hybridization, yet the
pp28 protein is seen in infected cells only at late times of
infection (25, 52, 53, 55, 56). Thus, pp28 is unlikely to be
translated from the larger messages, which appear at earlier
times of infection. The putative upstream polyadenylation sig-
nal located proximal to UL94 could represent the evolutionary
emergence of a new signal intended to allow processing of
messages upstream of UL95; indeed, in other herpesviruses,
the UL94 homolog does not appear to be present on large
transcripts containing the more downstream open reading
frames (16). Alternatively, the use of multiple polyadenylation
signals could provide a means of regulating the levels of pro-
teins translated from these messages.
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